Diagnostic imaging devices are used for the visualization of structural and functional patterns of organs or tissues. Nuclear imaging equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. GlobalData uses proprietary data and analytics to provide a comprehensive report on the nuclear imaging equipment devices market, including market shares of different players within Austria. Buy the latest report here.

Smarter leaders trust GlobalData


Data Insights Austria Nuclear Imaging Equipment Market Share

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

In 2021, GlobalData’s Market Model methodology determined that the leading player in the nuclear imaging equipment market in Austria was GE Healthcare followed by Siemens Healthineers, Philips Healthcare and Canon Medical Systems.

Nuclear imaging systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis. Positron emission tomography (PET) systems, positron emission tomography/computed tomography (PET/CT) systems, positron emission tomography/magnetic resonance imaging (PET/MRI) systems, single photon emission computed tomography (SPECT) systems and single photon emission computed tomography/computed tomography (SPECT /CT) systems are tracked under this category. A Positron Emission Tomography (PET) scan is an imaging test that helps reveal how your tissues and organs are functioning. PET-CT or PET/CT is a medical imaging technique using a device which combines in a single gantry system both a positron emission tomography (PET) scanner and an x-ray computed tomography (CT) scanner, so that images acquired from both devices can be taken sequentially, in the same session, and combined into a single superposed (co-registered) image. A PET/MRI system combines the functional information in regard to the metabolism or physiology, obtained from a PET scan, with morphological and anatomical imaging of soft tissues, obtained from a MRI scan. Single photon emission computed tomography (SPECT) is used to construct images of the distribution of the radioactive tracers in the human body by measuring the emission of single photons of a given energy from radioactive tracers. A SPECT/CT system is a technically advanced tomography system which combines the SPECT information with the anatomical data of a Computed Tomography (CT) scan to provide more information about the body.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the nuclear imaging equipment devices market within Austria was expected to be over $8m in 2021.

For the latest complete market share analysis of nuclear imaging equipment device market in Austria, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.